
The zzso zzso zzso initially cloned as a dominant inhibitor of the zzso zzso zzso zzso zzso encodes a key component of the cell fate determination zzso involved in zzso eye zzso Analysis of more than 2,200 breast cancer samples showed improved survival by some 40 months in patients whose tumors expressed zzso zzso zzso and zzso zzso zzso expressions were zzso correlated in human breast zzso zzso bound and inhibited zzso zzso Nuclear zzso expression inhibited zzso zzso DNA synthesis and cellular zzso zzso bound zzso in zzso zzso associated with zzso in zzso zzso and inhibited zzso zzso activity, requiring a zzso zzso zzso zzso analysis identified zzso zzso acid, and zzso rich protein 1 zzso as a zzso zzso The zzso zzso zzso was required for binding to zzso zzso inhibited induction of zzso zzso zzso recruited zzso and zzso zzso from zzso at an zzso zzso response element, allowing zzso to serve as an zzso zzso zzso zzso which is lost in poor prognosis human breast cancer, functions as an zzso inhibitor of zzso zzso 

